HORIBA Medical has established a partnership with BioMedica to enlarge the scope in hemostasis from routine panel to specialties

15 de julho de 2020


Biomedica Diagnostics

Montpellier, France, July 16th, 2020

Less than 2 years after the successful launch of its Yumizen G line of hemostasis analysers and an innovative routine reagents portfolio, HORIBA Medical has established a partnership with BioMedica Diagnostics Inc. (BMD), a specialized hemostasis Canadian company and a world supplier of reagents relating to the diagnosis and research of hemostatic and thrombotic disorders.

With the addition of these specialties to its menu of liquid and ready to use routine hemostasis reagents, HORIBA Medical is now positioned to offer solutions for specialized laboratories.

HORIBA Medical is internationally recognized and present in more than 150 countries through affiliates and distributors. 

Its expertise and innovative R&D in hematology has earned HORIBA Medical a world-wide reputation in the field of in vitro diagnostics. HORIBA Medical is the partner of choice for clinical and hematology/cytology laboratories and now obviously hemostasis/ thrombosis.

Please refer to your local HORIBA Medical contact or dealer as your contact for additional information on the new range of hemostasis analysers and reagents.

About BioMedica Diagnostics Inc.

BioMedica Diagnostics Inc., a proudly Canadian company, is a world supplier in the development, manufacture and marketing of novel assay systems and reagents relating to the diagnosis and research of hemostatic and thrombotic disorders.   Utilizing our innovative and proprietary technology, we offer a complete portfolio of routine and specialty coagulation products in over 70 countries world-wide.  By collaborating with technology manufacturers, platform developers, researchers, practitioners, and other leading stakeholders, we offer the highest quality products and services that can be trusted to contribute to delivering better patient outcomes.  For additional information, contact BioMedica Diagnostics at +1 902 798-5105, or visit our website at www.biomedicadiagnostics.com.

Today, HORIBA Medical is able to offer dedicated and specific solutions for Hemostasis diagnostic and treatment monitoring and to cover the needs of any laboratory with: 

 

The smallest analyzer for point of care laboratories to monitor oral anticoagulant.

Compact 2-channel instrument device dedicated for small laboratories to perform hemostasis screening and D-Dimer tests.

Compact 4-channel instrument designed for small laboratories to perform hemostasis screening and D-Dimer tests.

Automatic benchtop hemostasis analyzer for laboratories with mid-size workloads for routine & specialized tests including new Yumizen G DDi 2 (D-Dimer).

Fully automated, high-capacity hemostasis analyzer to manage the diagnostic and monitoring requirements of clinical laboratories with mid to high workload for routine & specialized tests including new Yumizen G DDi 2 (D-Dimer).